chronic hepatitis C virus (HCV)
Showing 1 - 25 of >10,000
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
Occult Hepatitis C Virus Infection in Patients Born Before 1969
Not yet recruiting
- Hepatitis C, Chronic
- +2 more
- Meridan Bioscience Point of Care test against HCV antibodies
- (no location specified)
Apr 2, 2023
Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)
Completed
- Chronic Hepatitis C Virus (HCV) Infection
- ABT-493/ABT-530
- Placebo for ABT-493/ABT-530
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- (no location specified)
Jul 8, 2021
Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)
Completed
- Hepatitis C, Chronic
- Opioid-use Disorder
-
Pittsburgh, PennsylvaniaMagee Womens Hospital of UPMC
Aug 19, 2022
Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)
Active, not recruiting
- Hepatitis C, Chronic
- Opioid Dependence, on Agonist Therapy
- Health care delivery
-
Bergen, Hordaland, Norway
- +1 more
Aug 5, 2022
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)
Recruiting
- HCV
- Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
-
Cairo, EgyptFaculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric
Completed
- Hepatitis C Virus (HCV)
- Glecaprevir/pibrentasvir adult formulation
- Glecaprevir/pibrentasvir pediatric formulation
-
San Francisco, California
- +37 more
Sep 19, 2022
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6
Completed
- Hepatitis C Virus (HCV)
-
Makhachkala, Dagestan, Respublika, Russian Federation
- +7 more
Jun 23, 2022
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)
Completed
- Hepatitis C Virus (HCV)
-
San Diego, California
- +24 more
Jul 14, 2021
Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult
Completed
- Hepatitis C Virus (HCV)
-
Chelyabinsk, Russian Federation
- +5 more
Jun 8, 2022